AS-252424
CAS No. 900515-16-4
AS-252424( AS252424 | AS 252424 | AS-252424 )
Catalog No. M16475 CAS No. 900515-16-4
AS-252424 is a potent and selective PI3Kγ inhibitor with an IC50 of 30±10 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 77 | In Stock |
|
| 2MG | 44 | In Stock |
|
| 5MG | 70 | In Stock |
|
| 10MG | 130 | In Stock |
|
| 25MG | 217 | In Stock |
|
| 50MG | 319 | In Stock |
|
| 100MG | 462 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1004 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAS-252424
-
NoteResearch use only, not for human use.
-
Brief DescriptionAS-252424 is a potent and selective PI3Kγ inhibitor with an IC50 of 30±10 nM.
-
DescriptionAS-252424 is a potent and selective PI3Kγ inhibitor with an IC50 of 30±10 nM.
-
In VitroAS-252424 also inhibits PI3Kα, PI3Kβ and PI3Kδ with IC50s of 935±150 nM, 20 μM and 20 μM, respectively. AS-252424 inhibits MCP-1-mediated chemotaxis in wild-type primary monocytes in a concentration-dependent manner with an IC50 value of 52 μM, as well as in the monocytic cell line THP-1 with an IC50 value of 53 μM. In the human monocytic cell line THP-1, MCP-1 binding to the GPCR chemokine receptor CCR2, strongly induces phosphorylation of PKB/Akt, which is effectively inhibited by AS-252424 at IC50 values as low as 0.4 μM. In contrast, induction of PKB/Akt phosphorylation by colony stimulating factor (CSF-1), binding to the growth factor receptor c-fms, is only blocked by AS-252424 at IC50 values as high as 4.7 μM.
-
In VivoOral administration of AS-252424 in a mouse model of acute peritonitis leads to a significant reduction of leukocyte recruitment. To evaluate the efficacy of AS-252424 to block leukocyte migration in vivo, it is tested in a mouse model of thioglycollate-induced peritonitis. Oral administration of AS-252424 at 10 mg/kg results in moderate reduction of neutrophil recruitment (35%±14%), almost matching the result observed in PI3Kγ-deficient mice. Given the short oral half-life of AS-252424 (t1/2=1 h) and relative high clearance (2.25 L/kg per h), investigations at later time points (24-48 h) to assess macrophage and monoycyte recruitment are not undertaken. The modest pharmacokinetic properties do not appear to be caused by rapid oxidative metabolism (microsomal metabolism after 1 h: 16% (rat), 10% (human)).
-
SynonymsAS252424 | AS 252424 | AS-252424
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorPI3Kγ| PI3Kα| Casein KiN/Ase 2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number900515-16-4
-
Formula Weight305.28
-
Molecular FormulaC??H?FNO?S
-
Purity>98% (HPLC)
-
SolubilityDMSO:30.5 mg/mL (100 mM)
-
SMILESO=C(NC/1=O)SC1=C/C2=CC=C(C3=CC=C(F)C=C3O)O2
-
Chemical Name(Z)-5-((5-(4-fluoro-2-hydroxyphenyl)furan-2-yl)methylene)thiazolidine-2,4-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Pomel V, et al. Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase gamma. J Med Chem. 2006 Jun 29;49(13):3857-71.
molnova catalog
related products
-
Parsaclisib HCl
Parsaclisib HCl is a selectve PI3Kδ inhibitor with antitumor activity. Parsaclisib demonstrates potent activity with IC50 values ranging from 0.2 to 2 nM.
-
mTOR inhibitor 9d
mTOR inhibitor 9d is a dual inhibitor of the protein kinases mTOR and PI3K with an mTOR IC50 value of 0.31 nm, and can be used for the treatment of leukemia, skin cancer, breast cancer, lung cancer and colon cancer.
-
GSK1016790A
GSK1016790A (GSK101) is a novel, potent activator of TRPV4 (transient receptor potential vanilloid 4) with EC50 of 34 nM in choroid plexus epithelial cells.
Cart
sales@molnova.com